New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

AIDP's KoACT gets GRAS status

AIDP's KoACT gets GRAS status
AIDP's chelated compound of calcium and hydrolyzed collagen peptides receives generally recognized as safe status.

KoACT, a patented chelated compound of calcium and hydrolyzed collagen peptides from AIDP, has received GRAS (Generally Recognized as Safe) status. KoACT has been shown to support both bone strength and bone mineral density in animal studies and to increase biomarkers of bone growth in human studies.

AIBMR Life Sciences, Inc., evaluated the safety assessment of KoACT and concluded its intended use as a food ingredient is produced in accordance with Good Manufacturing Practices. The AIBMR panel concluded that the addition levels per food serving are GRAS based upon scientific procedures and corroborated by an extensive history of safe use.

“The bone and joint health market are expected to reach over $4 billion by 2013, and we feel KoACT is positioned to take a large portion of that health category,” said Kathy Lund, director of business development and marketing.

Suggested delivery forms for KoACT are tablets, capsules, soft-gels and functional food applications.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.